• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环 2β发夹中的残基的电荷和几何形状差异地影响甘氨酸受体的激动剂和乙醇敏感性。

Charge and geometry of residues in the loop 2 β hairpin differentially affect agonist and ethanol sensitivity in glycine receptors.

机构信息

Alcohol and Brain Research Laboratories, Departments of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA.

出版信息

J Pharmacol Exp Ther. 2012 May;341(2):543-51. doi: 10.1124/jpet.111.190942. Epub 2012 Feb 22.

DOI:10.1124/jpet.111.190942
PMID:22357974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3336819/
Abstract

Recent studies highlighted the importance of loop 2 of α1 glycine receptors (GlyRs) in the propagation of ligand-binding energy to the channel gate. Mutations that changed polarity at position 52 in the β hairpin of loop 2 significantly affected sensitivity to ethanol. The present study extends the investigation to charged residues. We found that substituting alanine with the negative glutamate at position 52 (A52E) significantly left-shifted the glycine concentration response curve and increased sensitivity to ethanol, whereas the negative aspartate substitution (A52D) significantly right-shifted the glycine EC₅₀ but did not affect ethanol sensitivity. It is noteworthy that the uncharged glutamine at position 52 (A52Q) caused only a small right shift of the glycine EC₅₀ while increasing ethanol sensitivity as much as A52E. In contrast, the shorter uncharged asparagine (A52N) caused the greatest right shift of glycine EC₅₀ and reduced ethanol sensitivity to half of wild type. Collectively, these findings suggest that charge interactions determined by the specific geometry of the amino acid at position 52 (e.g., the 1-Å chain length difference between aspartate and glutamate) play differential roles in receptor sensitivity to agonist and ethanol. We interpret these results in terms of a new homology model of GlyR based on a prokaryotic ion channel and propose that these mutations form salt bridges to residues across the β hairpin (A52E-R59 and A52N-D57). We hypothesize that these electrostatic interactions distort loop 2, thereby changing agonist activation and ethanol modulation. This knowledge will help to define the key physical-chemical parameters that cause the actions of ethanol in GlyRs.

摘要

最近的研究强调了α1 甘氨酸受体(GlyRs)loop 2 在配体结合能量传递到通道门的过程中的重要性。在 loop 2 的β发夹中位置 52 改变极性的突变显著影响了对乙醇的敏感性。本研究将调查范围扩展到带电残基。我们发现,在位置 52 用带负电荷的谷氨酸取代丙氨酸(A52E)会显著左移甘氨酸浓度反应曲线并增加对乙醇的敏感性,而带负电荷的天冬氨酸取代(A52D)则显著右移甘氨酸 EC₅₀,但不影响乙醇敏感性。值得注意的是,位置 52 的不带电荷的谷氨酰胺(A52Q)仅导致甘氨酸 EC₅₀ 发生较小的右移,同时增加了对乙醇的敏感性,就像 A52E 一样。相比之下,较短的不带电荷的天冬酰胺(A52N)导致甘氨酸 EC₅₀ 发生最大的右移,并将乙醇敏感性降低至野生型的一半。总的来说,这些发现表明,位置 52 处氨基酸的特定几何形状决定的电荷相互作用(例如,天冬氨酸和谷氨酸之间的 1 Å 链长差异)在受体对激动剂和乙醇的敏感性中发挥着不同的作用。我们根据一个原核离子通道的同源模型来解释这些结果,并提出这些突变形成了与 β 发夹中跨残基的盐桥(A52E-R59 和 A52N-D57)。我们假设这些静电相互作用扭曲了 loop 2,从而改变了激动剂的激活和乙醇的调节。这一知识将有助于确定导致乙醇在 GlyRs 中作用的关键物理化学参数。

相似文献

1
Charge and geometry of residues in the loop 2 β hairpin differentially affect agonist and ethanol sensitivity in glycine receptors.环 2β发夹中的残基的电荷和几何形状差异地影响甘氨酸受体的激动剂和乙醇敏感性。
J Pharmacol Exp Ther. 2012 May;341(2):543-51. doi: 10.1124/jpet.111.190942. Epub 2012 Feb 22.
2
Roles for loop 2 residues of alpha1 glycine receptors in agonist activation.α1甘氨酸受体2号环残基在激动剂激活中的作用。
J Biol Chem. 2008 Oct 10;283(41):27698-27706. doi: 10.1074/jbc.M802384200. Epub 2008 Jul 25.
3
Loop 2 structure in glycine and GABA(A) receptors plays a key role in determining ethanol sensitivity.甘氨酸和γ-氨基丁酸A(GABA(A))受体中的环2结构在决定乙醇敏感性方面起着关键作用。
J Biol Chem. 2009 Oct 2;284(40):27304-14. doi: 10.1074/jbc.M109.023598. Epub 2009 Aug 5.
4
Characterization of two mutations, M287L and Q266I, in the α1 glycine receptor subunit that modify sensitivity to alcohols.鉴定两个突变,M287L 和 Q266I,在α1 甘氨酸受体亚基上,改变对酒精的敏感性。
J Pharmacol Exp Ther. 2012 Feb;340(2):304-16. doi: 10.1124/jpet.111.185116. Epub 2011 Oct 28.
5
Manipulations of extracellular Loop 2 in α1 GlyR ultra-sensitive ethanol receptors (USERs) enhance receptor sensitivity to isoflurane, ethanol, and lidocaine, but not propofol.对α1甘氨酸受体超敏乙醇受体(USERs)胞外环2的操作可增强受体对异氟烷、乙醇和利多卡因的敏感性,但对丙泊酚无此作用。
Neuroscience. 2015 Jun 25;297:68-77. doi: 10.1016/j.neuroscience.2015.03.034. Epub 2015 Mar 28.
6
Disruption of a putative intersubunit electrostatic bond enhances agonist efficacy at the human α1 glycine receptor.一种假定的亚基间静电键的破坏增强了激动剂对人α1甘氨酸受体的效力。
Brain Res. 2017 Feb 15;1657:148-155. doi: 10.1016/j.brainres.2016.11.024. Epub 2016 Dec 5.
7
The basic property of Lys385 is important for potentiation of the human α1 glycine receptor by ethanol.赖氨酸 385 的基本特性对乙醇增强人α1 甘氨酸受体的作用很重要。
J Pharmacol Exp Ther. 2012 Feb;340(2):339-49. doi: 10.1124/jpet.111.185140. Epub 2011 Oct 31.
8
Ethanol Modulation is Quantitatively Determined by the Transmembrane Domain of Human α1 Glycine Receptors.乙醇调节作用由人α1甘氨酸受体的跨膜结构域定量决定。
Alcohol Clin Exp Res. 2015 Jun;39(6):962-8. doi: 10.1111/acer.12735. Epub 2015 May 14.
9
Targets for ethanol action and antagonism in loop 2 of the extracellular domain of glycine receptors.甘氨酸受体细胞外结构域第2环中乙醇作用和拮抗作用的靶点。
J Neurochem. 2008 Aug;106(3):1337-49. doi: 10.1111/j.1471-4159.2008.05476.x. Epub 2008 May 12.
10
The Startle Disease Mutation E103K Impairs Activation of Human Homomeric α1 Glycine Receptors by Disrupting an Intersubunit Salt Bridge across the Agonist Binding Site.惊吓病突变E103K通过破坏跨激动剂结合位点的亚基间盐桥来损害人同源性α1甘氨酸受体的激活。
J Biol Chem. 2017 Mar 24;292(12):5031-5042. doi: 10.1074/jbc.M116.767616. Epub 2017 Feb 7.

引用本文的文献

1
Structural Basis of Alcohol Inhibition of the Pentameric Ligand-Gated Ion Channel ELIC.酒精对五聚体配体门控离子通道ELIC抑制作用的结构基础
Structure. 2017 Jan 3;25(1):180-187. doi: 10.1016/j.str.2016.11.007. Epub 2016 Dec 1.
2
Ethanol effects on glycinergic transmission: From molecular pharmacology to behavior responses.乙醇对甘氨酸能传递的影响:从分子药理学到行为反应
Pharmacol Res. 2015 Nov;101:18-29. doi: 10.1016/j.phrs.2015.07.002. Epub 2015 Jul 6.
3
Ethanol Modulation is Quantitatively Determined by the Transmembrane Domain of Human α1 Glycine Receptors.乙醇调节作用由人α1甘氨酸受体的跨膜结构域定量决定。
Alcohol Clin Exp Res. 2015 Jun;39(6):962-8. doi: 10.1111/acer.12735. Epub 2015 May 14.
4
Manipulations of extracellular Loop 2 in α1 GlyR ultra-sensitive ethanol receptors (USERs) enhance receptor sensitivity to isoflurane, ethanol, and lidocaine, but not propofol.对α1甘氨酸受体超敏乙醇受体(USERs)胞外环2的操作可增强受体对异氟烷、乙醇和利多卡因的敏感性,但对丙泊酚无此作用。
Neuroscience. 2015 Jun 25;297:68-77. doi: 10.1016/j.neuroscience.2015.03.034. Epub 2015 Mar 28.
5
Control of ethanol sensitivity of the glycine receptor α3 subunit by transmembrane 2, the intracellular splice cassette and C-terminal domains.跨膜 2 区、胞内剪接盒及 C 末端域对甘氨酸受体 α3 亚基的乙醇敏感性的控制作用。
J Pharmacol Exp Ther. 2015 Apr;353(1):80-90. doi: 10.1124/jpet.114.221143.
6
Glycine and GABA(A) ultra-sensitive ethanol receptors as novel tools for alcohol and brain research.甘氨酸和GABA(A)超敏乙醇受体作为酒精与大脑研究的新工具。
Mol Pharmacol. 2014 Dec;86(6):635-46. doi: 10.1124/mol.114.093773. Epub 2014 Sep 22.
7
Alcohol dependence: molecular and behavioral evidence.酒精依赖:分子与行为证据。
Trends Pharmacol Sci. 2014 Jul;35(7):317-23. doi: 10.1016/j.tips.2014.04.009. Epub 2014 May 25.
8
Seeking structural specificity: direct modulation of pentameric ligand-gated ion channels by alcohols and general anesthetics.探寻结构特异性:醇类和全身麻醉药对五聚体配体门控离子通道的直接调控
Pharmacol Rev. 2014 Feb 10;66(2):396-412. doi: 10.1124/pr.113.007468. Print 2014.
9
Structural models of ligand-gated ion channels: sites of action for anesthetics and ethanol.配体门控离子通道的结构模型:麻醉剂和乙醇的作用位点
Alcohol Clin Exp Res. 2014 Mar;38(3):595-603. doi: 10.1111/acer.12283. Epub 2013 Oct 24.
10
Minireview: applied structural bioinformatics in proteomics.综述:蛋白质组学中的应用结构生物信息学。
Protein J. 2013 Oct;32(7):505-11. doi: 10.1007/s10930-013-9514-1.

本文引用的文献

1
Principles of activation and permeation in an anion-selective Cys-loop receptor.阴离子选择性 Cys 环受体的激活和渗透原理。
Nature. 2011 Jun 2;474(7349):54-60. doi: 10.1038/nature10139. Epub 2011 May 15.
2
Microsecond simulations indicate that ethanol binds between subunits and could stabilize an open-state model of a glycine receptor.微秒级模拟表明,乙醇结合在亚基之间,可能稳定甘氨酸受体的开放态模型。
Biophys J. 2011 Apr 6;100(7):1642-50. doi: 10.1016/j.bpj.2011.02.032.
3
X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel.与五聚体配体门控离子通道结合的全身麻醉剂的 X 射线结构。
Nature. 2011 Jan 20;469(7330):428-31. doi: 10.1038/nature09647.
4
Modeling anesthetic binding sites within the glycine alpha one receptor based on prokaryotic ion channel templates: the problem with TM4.基于原核离子通道模板对甘氨酸 alpha 1 受体中麻醉结合位点进行建模:TM4 存在的问题。
J Chem Inf Model. 2010 Dec 27;50(12):2248-55. doi: 10.1021/ci100266c. Epub 2010 Nov 30.
5
Glycine hinges with opposing actions at the acetylcholine receptor-channel transmitter binding site.甘氨酸铰链在乙酰胆碱受体-通道递质结合位点具有相反的作用。
Mol Pharmacol. 2011 Mar;79(3):351-9. doi: 10.1124/mol.110.068767. Epub 2010 Nov 29.
6
Pore opening and closing of a pentameric ligand-gated ion channel.五聚体配体门控离子通道的孔道开启和关闭。
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19814-9. doi: 10.1073/pnas.1009313107. Epub 2010 Nov 1.
7
Conformational changes in extracellular loop 2 associated with signal transduction in the glycine receptor.与甘氨酸受体信号转导相关的细胞外环 2 的构象变化。
J Neurochem. 2010 Dec;115(5):1245-55. doi: 10.1111/j.1471-4159.2010.07021.x. Epub 2010 Oct 21.
8
3D structure and allosteric modulation of the transmembrane domain of pentameric ligand-gated ion channels.五聚体配体门控离子通道跨膜域的 3D 结构和别构调节。
Neuropharmacology. 2011 Jan;60(1):116-25. doi: 10.1016/j.neuropharm.2010.08.007. Epub 2010 Aug 14.
9
Alcohol- and alcohol antagonist-sensitive human GABAA receptors: tracking δ subunit incorporation into functional receptors.酒精和酒精拮抗剂敏感的人类 GABAA 受体:追踪 δ 亚基整合入功能性受体。
Mol Pharmacol. 2010 Nov;78(5):918-24. doi: 10.1124/mol.109.062687. Epub 2010 Aug 10.
10
Molecular targets and mechanisms for ethanol action in glycine receptors.甘氨酸受体中乙醇作用的分子靶点和机制。
Pharmacol Ther. 2010 Jul;127(1):53-65. doi: 10.1016/j.pharmthera.2010.03.003. Epub 2010 Apr 23.